Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience. (13th March 2021) - Jurgensen‐Rauch, Amanda; Gibbs, Suzanne; Farrell, Maresa; Aries, James; Grantham, Marianne; Eccersley, Lydia; Gribben, John; Hallam, Simon; Oakervee, Heather; Cavenagh, Jamie; Davies, Jeff; Sive, Jonathan